首页|利奈唑胺联合免疫球蛋白治疗新生儿败血症的效果观察

利奈唑胺联合免疫球蛋白治疗新生儿败血症的效果观察

扫码查看
目的 分析利奈唑胺联合免疫球蛋白治疗新生儿败血症的效果。方法 选取北京市房山区良乡医院 2020 年 8 月~2023 年 8 月新生儿败血症 92 例为研究对象,随机分为两组。对照组(46 例)采用利奈唑胺进行治疗,研究组(46 例)采用利奈唑胺联合免疫球蛋白治疗。比较两组患儿临床疗效、炎症因子水平、免疫功能、症状体征改善情况。结果 治疗后,研究组白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、超敏C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)水平低于对照组(P<0。05);治疗前,两组免疫球蛋白M(IgM)、免疫球蛋白A(IgA)、免疫球蛋白G(IgG)差异无统计学意义(P>0。05),治疗后两组IgM差异无统计学意义(P>0。05),研究组IgA、IgG高于对照组(P<0。05);研究组总有效率高于对照组(P<0。05);研究组各症状改善时间短于对照组(P<0。05)。结论 利奈唑胺联合免疫球蛋白治疗新生儿败血症效果较好,可加速病情恢复,提高免疫功能,改善炎症因子水平。
Observation of the effect of linezolid combined with immunoglobulin in the treatment of neonatal septicemia
Objective To analyze the effect of linezolid combined with immunoglobulin in the treatment of neonatal septicemia.Methods 92 cases of neonatal septicemia from Liangxiang Hospital of Fangshan District of Beijing from August 2020 to August 2023 were selected as the study objects and randomly divided into two groups.The control group(46 cases)was treated with linezolid,the study group(46 cases)was treated with linezolid combined with immunoglobulin.The clinical efficacy,levels of inflammatory factors,immune function and improvement of symptoms and signs were compared between the two groups.Results After treatment,the levels of IL-6,IL-8,hs-CRP and TNF-α in the study group were lower than those in the control group(P<0.05).Before treatment,there were no significant difference in IgM,IgA and IgG between two groups.After treatment,no significant difference in IgM between two groups(P>0.05).IgA and IgG in the study group were higher than those in the control group(P<0.05).The total effective rate of the study group was higher than that of the control group(P<0.05).The improvement time of symptoms in the study group was shorter than that in the control group(P<0.05).Conclusion Linezolid combined with immunoglobulin is effective in the treatment of neonatal septicemia,which can accelerate the recovery of children condition,improve the immune function and improve the level of inflammatory factors in children.

LinezolidImmunoglobulinNeonatal septicemia

程颖、邰怡、葛柳源、王金环

展开 >

北京市房山区良乡医院儿科,北京 102400

中国人民解放军总医院第七医学中心血液净化中心,北京 100000

利奈唑胺 免疫球蛋白 新生儿败血症

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(7)